Rheumatoid arthritis and cardiovascular disease: What is known about this relationship and what can currently be done for affected patients?;Artrite reumatóide e doença cardiovascular: O que sabemos e o que podemos fazer pelo paciente na atualidade?

Revista Portuguesa de Cardiologia

Volumn 31, Issue 3, 2012, Pages 225-232

  Soeiro, Alexandre De Matos ^a   Haddad, Michel ^a   De Almeida, Maria Carolina Feres ^a   Ruppert, Aline D ^a   Serrano Jr , Carlos V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiovascular disease; Inflammation; Rheumatoid arthritis

Indexed keywords

CARDIOVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMAN; INFLAMMATION; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT;

EID: 84860576540     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2012.01.005     Document Type: Short Survey

References (37)

1. Marques Neto JF, Gonçalves ET, Langen LFOB, et al. Multicentric study of the prevalence of adult rheumatoid arthritis in Brazilian population samples. Rev Bras Reumatol. 1993;33:169-73.
2. Haque S, Mirjafari H, Bruce IN. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Curr Opin Lipidol. 2008;19:338-43.
3. Turesson C, Jarenros A, Jacobsson L. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis. 2004;63:952-5. (Pubitemid 38961920)
4. Rindfleisch JA, Muller D. Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2005;72:1037-47.
5. Hürlimann D, Enseleit F, Ruschitzka F. Rheumatoide Arthritis, Inflammation und Atherosklerose. Herz. 2004;29:760-8.
6. Gabriel SE. Heart disease and rheumatoid arthritis: understanding the risks. Ann Rheum Dis. 2010;69:i61-4.
7. Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med. 2008;121:S9-14.
8. Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum. 2003;48:54-8. (Pubitemid 36091647)
9. Chung CP, Oeser A, Avalos I, et al. Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther. 2006;8:R186.
10. Sitia S, Atzeni F, Sarzi-Puttini P, et al. Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev. 2009;8:281-6.
11. Brenol CV, Monticielo OA, Xavier RM. Atrite reumatoide e aterosclerose. Rev Assoc Med Bras. 2007;53:465-70.
12. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum. 2005;35:8-17. (Pubitemid 41111466)
13. Wolfe F, Michaud K. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med. 2004;116:305-11. (Pubitemid 38230289)
14. Guzmán AL, Díaz JDG, De la Vacas MID, et al. Coronary calcification and subclinical myocardial dysfunction in rheumatoid arthritis. Rev Clin Esp. 2009;209:428-32.
15. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005;52:402-11. (Pubitemid 40220344)
16. Chung CP, Avalos I, Raggi P, et al. Atherosclerosis and inflammation: insights from rheumatoid arthritis. Clin Rheumatol. 2007;26:1228-33. (Pubitemid 47034173)
17. Myasoedova E, Crowson CS, Kremers HM, et al. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis. 2010;69:1310-4.
18. Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis. Ann Rheum Dis. 2007;66:76-80. (Pubitemid 46044863)
19. Nicola PJ, Maradit-Kremers H, Roger VL, et al. The risk of congestive heart failure in rheumatoid arthristis. Arthritis and Rheum. 2005;52:412-20.
20. Liang KP, Kremers HM, Crowson CS, et al. Autoantibodies and the risk of cardiovascular events. J Rheumatol. 2009;36:2462-9.
21. Giles JT, Szklo M, Post W, et al. Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis. Arthritis Res Ther. 2009;11:R36.
22. Sodergen A, Stegmayr B, Lundberg V, et al. Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis. Ann Rheum Dis. 2007;66:263-6. (Pubitemid 46226067)
23. Aubry MC, Maradit-Kremers H, Reinalda MS, et al. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol. 2007;34:937-42. (Pubitemid 46774835)
24. Wang S, Yiu KH, Mok MY, et al. Prevalence and extent of calcification over aorta, coronary and carotid arteries in patients with rheumatoid arthritis. J Intern Med. 2009;266:445-52.
25. Crowson CS, Nicola PJ, Kremers HM, et al. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis and Rheum. 2005;52: 3039-44. (Pubitemid 41447083)
26. Liang KP, Myasoedova E, Crowson CS, et al. Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis. 2010;69:1665-70.
27. Kao AH, Wasko MCM, Krishnaswami S, et al. C-Reactive Protein and Coronary Artery Calcium in Asymptomatic Women With Systemic Lupus Erythematosus or Rheumatoid Arthritis. Am J Cardiol. 2008;102:755-60.
28. Davis JM, Kremers HM, Crowson CS, et al. Glucocorticoids and cardiovascular events in rheumatoid arthritis. Arthritis and Rheum. 2007;56:820-30.
29. Park YB, Choi HK, Kim MY, et al. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med. 2002;113:188-93. (Pubitemid 35245626)
30. Landewé RB, Van den Borne BEEM, Breedveld FC, et al. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet. 2000;355:1616-7.
31. Van Halm VP, Nurmohamed MT, Twisk JWR, et al. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Research & Therapy. 2006;8:R151.
32. Choi HK, Hernán MA, Seeger JD. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359:1173-7.
33. Suissa S, Bernatsky S, Hudson M. Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Rheum. 2006;55:531-6. (Pubitemid 44289870)
34. Bosello S, Santoliquido A, Zoli A, et al. TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. Clin Rheumatol. 2008;27:833-9.
35. Peters MJL, Vis M, Van Halm VP, et al. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis. Ann Rheum Dis. 2007;66:958-61. (Pubitemid 46999801)
36. Maki-Petaja KM, Booth AD, Hall FC, et al. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol. 2007;50:852-8. (Pubitemid 47268750)
37. IV Diretriz Brasileira Sobre Dislipidemias e Prevenção da Aterosclerose. Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2007;88:1-19.